Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics
- 1 May 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 5 (5), 1275-1279
- https://doi.org/10.1158/1535-7163.mct-06-0024
Abstract
The extracellular pH of tumor tissue is significantly lower than the extracellular pH of normal tissue, whereas the intracellular pH of both tissues is similar. In principle, extracellular acidity may be expected to enhance the intracellular uptake and cytotoxicity of weak acid chemotherapeutics that are membrane permeable in their uncharged state and inhibit the efficacy of weak bases. However, procedures for assessing the role of the gradient as a determinant of drug efficacy in vivo by altering the pH gradient may also alter drug availability and thus mask or exaggerate the effect of the gradient change. In the present study, we have altered the extracellular pH of tumors and compared the effect of the resultant pH gradient change on the efficacy of a weak acid versus a weak base. This experimental design gives rise to a change in the ratio of chlorambucil- to doxorubicin-induced tumor growth delay, independent of possible changes in drug availability. The extracellular pH of the 54A human tumor in NCr/Sed/nu/nu mice was altered by administration of 5 mg/g i.v. glucose. The resultant 0.2 pH unit increase in the tumor cell pH gradient gives rise to a predicted 2.3-fold increase in the ratio of chlorambucil to doxorubicin growth delay. The experimentally measured change in the growth delay ratio was 2.1. The results provide compelling evidence that the pH gradient in a determinant of the efficacy of weak electrolytes in the complex in vivo environment and may be exploited for the treatment of cancer.This publication has 26 references indexed in Scilit:
- Tumor acidity, ion trapping and chemotherapeutics: I. Acid pH affects the distribution of chemotherapeutic agents in vitroBiochemical Pharmacology, 2003
- Tumor acidity, ion trapping and chemotherapeuticsBiochemical Pharmacology, 2003
- The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a surveyChemistry and Physics of Lipids, 1990
- Relations between ph, oxygen partial pressure and growth in cultured cell spheroidsInternational Journal of Cancer, 1988
- Extracellular pH, transmembrane distribution and cytotoxicity of chlorambucilBiochemical Pharmacology, 1985
- Binding of adriamycin to sulphated mucopolysaccharidesBiochemical and Biophysical Research Communications, 1978
- Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1977
- Binding of daunomycin to nonhistone proteins from rat liverBiochimica et Biophysica Acta (BBA) - Protein Structure, 1976
- pH STUDIES IN HUMAN MALIGNANT TUMOURSThe Lancet, 1966
- CALCULATION OF INTRACELLULAR pH FROM THE DISTRIBUTION OF 5,5-DIMETHYL-2,4-OXAZOLIDINEDIONE (DMO). APPLICATION TO SKELETAL MUSCLE OF THE DOG*JCI Insight, 1959